Reticulated platelets – a new risk factor of atherothrombosis?
| Autor: | S. G. Khaspekova, O. N. Shustova, V. V. Bodrova, A. V. Mazurov |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Population
antiplatelet drugs 030204 cardiovascular system & hematology Pharmacology 03 medical and health sciences 0302 clinical medicine P2Y12 Megakaryocyte atherothrombosis medicine Platelet 030212 general & internal medicine Platelet activation reticulated platelets education Internal medicine education.field_of_study Aspirin Chemistry RNA General Medicine RC31-1245 cardiovascular diseases medicine.anatomical_structure platelets Bone marrow medicine.drug |
| Zdroj: | Атеротромбоз, Vol 0, Iss 1, Pp 144-156 (2021) |
| ISSN: | 2658-5952 2307-1109 |
| DOI: | 10.21518/2307-1109-2021-11-1-144-156 |
| Popis: | In this review we described the properties of reticulated platelets (RP) and showed how variations of their content might influence platelet activity, efficacy of antiplatelet drugs and the rate of thrombotic events in patients with cardiovascular diseases. RP represent a minor platelet fraction containing residual RNA from megakaryocytes. Platelets have no nucleus and do not synthesize RNA de novo, and RNA of megakaryocytic origin is destroyed during their circulation. That is why only recently produced “young” platelets contain RNA. In healthy donors RP are identified by staining with the RNA specific fluorescent dyes by flow cytofluorimetry or using standard protocols in modern flow haematological analyzers. RP content in blood reflects the level of thrombocytopoesis in the bone marrow. RP on average amounted from 3 to 10% of all platelets in the circulation depending on the method applied for their determination. RP absolute amount and/or their percentage is changed in haematological diseases associated with the alterations of megakaryocyte productive properties. RT measurements in patients with cardiovascular diseases have shown that their content is increased in acute coronary syndrome patients. RP are larger and functionally more active in comparison with not reticulated forms. They more frequently incorporate into the platelet aggregates and contain more intracellular granules. Increase of RT content in the circulation correlates with the increase of the average size and functional activity in the whole platelet population. High RP content in patients with cardiovascular diseases reduces antiaggregative effects of aspirin and P2Y12 APD receptor antagonists and increases the risk of atherothrombotic events. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|